ConductScience.org, home

Paper39338348

Dehydroepiandrosterone and Its Metabolite 5-Androstenediol: New Therapeutic Targets and Possibilities for Clinical Application.

Fedotcheva TA and 3 others. Pharmaceuticals (Basel), 2024. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Dehydroepiandrosterone and Its Metabolite 5-Androstenediol: New Therapeutic Targets and Possibilities for Clinical Application. Papers, record 39338348. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39338348

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Dehydroepiandrosterone and Its Metabolite 5-Androstenediol: New Therapeutic Targets and Possibilities for Clinical Application.
PubMed
Journal
Pharmaceuticals (Basel)
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
1.75, provisional
iCite
Revised in PubMed
2024-09-30
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fedotcheva TATatiana Ahttps://orcid.org/0000-0003-4998-9991
2Uspenskaya MEMaria Ehttps://orcid.org/0009-0003-3568-5513
3Ulchenko DNDarya Nhttps://orcid.org/0009-0008-1894-5746
4Shimanovsky NLNikolay L

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
24-24-00280Russian Science FoundationPubMed

Source PubMed

Download CSV of grants

References126

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119752325Dehydroepiandrosterone reverses systemic vascular remodeling through the inhibition of the Akt/GSK3-{beta}/NFAT axis.Circulation2009https://conductscience.org/library/papers/19752325PubMed
220691987Dehydroepiandrosterone during sepsis: does the timing of administration influence the effectiveness.J Surg Res2010https://conductscience.org/library/papers/20691987PubMed
326291918Serum levels of sex steroids and metabolites following 12 weeks of intravaginal 0.50% DHEA administration.J Steroid Biochem Mol Biol2015https://conductscience.org/library/papers/26291918PubMed
430326923Central intracrine DHEA synthesis in ageing-related neuroinflammation and neurodegeneration: therapeutic potential?J Neuroinflammation2018https://conductscience.org/library/papers/30326923PubMed
538007170Neuroactive steroids and Parkinson's disease: Review of human and animal studies.Neurosci Biobehav Rev2024https://conductscience.org/library/papers/38007170PubMed
622032408Dehydroepiandrosterone (DHEA)--a precursor steroid or an active hormone in human physiology.J Sex Med2011https://conductscience.org/library/papers/22032408PubMed
721541365Neurosteroid dehydroepiandrosterone interacts with nerve growth factor (NGF) receptors, preventing neuronal apoptosis.PLoS Biol2011https://conductscience.org/library/papers/21541365PubMed
816407456G protein-associated, specific membrane binding sites mediate the neuroprotective effect of dehydroepiandrosterone.FASEB J2006https://conductscience.org/library/papers/16407456PubMed
935582271Components of the human-specific, p53-mediated "kill switch" tumor suppression mechanism are usurped by human tumors, creating the possibility of therapeutic exploitation.Cancer Drug Resist2019https://conductscience.org/library/papers/35582271PubMed
1035056103The Utilization of Dehydroepiandrosterone as a Sexual Hormone Precursor in Premenopausal and Postmenopausal Women: An Overview.Pharmaceuticals (Basel)2021https://conductscience.org/library/papers/35056103PubMed
119876338The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women.Clin Endocrinol (Oxf)1998https://conductscience.org/library/papers/9876338PubMed
1223123738DHEA metabolites activate estrogen receptors alpha and beta.Steroids2013https://conductscience.org/library/papers/23123738PubMed
1319836365Pharmacokinetic and tissue distribution study of [14C]fluasterone in male Beagle dogs following intravenous, oral and subcutaneous dosing routes.Chem Biol Interact2010https://conductscience.org/library/papers/19836365PubMed
1415832488Effects of dehydroepiandrosterone on bone mineral density: what implications for therapy?Treat Endocrinol2002https://conductscience.org/library/papers/15832488PubMed
1530029723Dehydroepiandrosterone Research: Past, Current, and Future.Vitam Horm2018https://conductscience.org/library/papers/30029723PubMed
1610480450Correlation between the administered dose of DHEA and serum levels of DHEA and DHEA-S in human volunteers: analysis of published data.Clin Biochem1999https://conductscience.org/library/papers/10480450PubMed
1730959020The novel dehydroepiandrosterone (DHEA) derivative BNN27 counteracts behavioural deficits induced by the NMDA receptor antagonist ketamine in rats.Neuropharmacology2019https://conductscience.org/library/papers/30959020PubMed
1811194714DHEA: A forgettable steroid?J Endocrinol Invest2000https://conductscience.org/library/papers/11194714PubMed
1928082899BNN27, a 17-Spiroepoxy Steroid Derivative, Interacts With and Activates p75 Neurotrophin Receptor, Rescuing Cerebellar Granule Neurons from Apoptosis.Front Pharmacol2016https://conductscience.org/library/papers/28082899PubMed
2034089761On the role of sex steroids in biological functions by classical and non-classical pathways. An update.Front Neuroendocrinol2021https://conductscience.org/library/papers/34089761PubMed

See all 126 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
42653433Sarcopenia and Frailty in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): The Impact of Steroid Hormones.Int J Mol Sci2026https://conductscience.org/library/papers/42653433PubMed
42177729Exploratory gut microbiota-host interaction in parkinson's disease: integrative multi-omics analysis of metabolic and epigenetic pathways.AMB Express2026https://conductscience.org/library/papers/42177729PubMed
41090700Association of Hormonal Status With Sarcopenia, Frailty and Outcome in Patients With Decompensated Cirrhosis.Liver Int2025https://conductscience.org/library/papers/41090700PubMed
40877650Pharmacobiochemical Analysis of the Cytoprotective Action of New 5-Androstendiol Derivatives.Bull Exp Biol Med2025https://conductscience.org/library/papers/40877650PubMed
40732235Neurosteroids Progesterone and Dehydroepiandrosterone: Molecular Mechanisms of Action in Neuroprotection and Neuroinflammation.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40732235PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39338348

GET https://conductscience.org/api/papers/v1/39338348/references?page=2